Italia markets closed

BMY Oct 2024 65.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,09000,0000 (0,00%)
Alla chiusura: 02:05PM EDT
Schermo intero
Chiusura precedente0,0900
Aperto0,0900
Denaro0,0500
Lettera0,3500
Prezzo d'esercizio65,00
Scadenza2024-10-18
Min-Max giorno0,0900 - 0,0900
Contratto - Min-MaxN/D
Volume2
Open Interest1,78k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri